21 CFR Subpart B
New Drug or Prescription Status of Specific Drugs
June 25, 2020
§
250.100
Amyl nitrite inhalant as a prescription drug for human use
§
250.101
Amphetamine and methamphetamine inhalers regarded as prescription drugs
§
250.102
Drug preparations intended for human use containing certain “coronary vasodilators”
§
§250.103-250.104
[Reserved]
§
250.105
Gelsemium-containing preparations regarded as prescription drugs
§
§250.106-250.107
[Reserved]
§
250.108
Potassium permanganate preparations as prescription drugs